Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3

Sponsor and Collaborators     
M.D. Anderson Cancer Center
Bayer
Genzyme
Onyx Pharmaceuticals

Contact
Michael Andreeff, MD, PhD     
713-792-7260


Continue Reading

Investigator
Michael Andreeff, MD, PhD     
M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier
NCT00943943